Warning about fake diabetes ads and endorsements of products 5 May 2025 Diabetes Australia is alerting our community to the rise of fraudulent advertisements and scams for bogus products, including those that claim false endorsement by Diabetes Australia. Scammers are using deceptive tactics, including fake endorsements from supposed doctors and misleading claims about product origins, to market questionable blood glucose monitoring devices and other products to vulnerable individuals. One such scam involves a device marketed as the “Bikenda Non-Invasive Blood Glucose Meter,” falsely described as Australian-made and, in some advertisements, Diabetes Australia-approved. These ads, often appearing on social media platforms such as Facebook, are designed to exploit trust and target individuals managing diabetes. While scammers frequently rotate the products they promote, their methods are consistent: they publish fabricated claims and unauthorised use of reputable names to boost credibility. To protect our community, we have partnered with a leading cybersecurity company to monitor websites and social media platforms and are taking action to report and remove misleading advertisements, fake social media accounts and fraudulent websites as quickly as possible. Additionally, we treat every email and phone call reporting scam activity seriously, conducting thorough investigations to ensure prompt and appropriate action is taken. We strongly advise our community to remain vigilant and verify product claims through trusted sources before making any purchases. If you encounter suspicious advertisements or claims involving Diabetes Australia’s name, please take the following steps: Avoid engagement: Do not click on links, share, or purchase products promoted in such advertisements. Report scams: File a complaint with the Australian Competition and Consumer Commission (ACCC) via their Scamwatch website. Notify us: Report instances of fraud using our name to Diabetes Australia so we can investigate at [email protected] and take action. Contact the TGA: If you suspect a product is being falsely advertised as compliant, report it to the Therapeutic Goods Administration (TGA) at TGA Compliance Hub. We are committed to protecting our community from misleading and harmful practices. By staying informed and vigilant, we can collectively fight back against these scams and safeguard the trust placed in our organisation. This post was originally published on 9 January 2025. It was updated 5 May 2025.
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
Blog 27 May 2026 How diabetes, depression, anxiety, and medicines are connected People with diabetes can be depressed or anxious more often than people without diabetes. Studies show that when you have diabetes, you are almost twice as likely to be depressed, regardless of the type of diabetes. Continue Reading